1Mabro M,Louvet C Andre T,et al.Bimonthly Leucovorin,infusion 5-fluorouracil,hydroxyurea,and irinotecan(FOLFIRI-2)for pretreated metastatic colorectal cancer.Am J Clin Oncol,2003,26:254-258. 被引量：1
2Saltz LB,Cox JV,Blanke C,et al.Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer.Irinotecan Study Group.N Eng1 J Med,2000,343:905-914. 被引量：1
3Douillard JY,Cunningham D,Roth AD,et al.Irinotecan combined with fluorouracil alone as first-line treatment for metastatic colorectal cancer;a multicentre randomized trial.Lancet,2000,355:1041-1047. 被引量：1
4Kim R,Yamaguchi Y,Toge T.Adjuvant therapy for colorectal carcinoma.Anticancer Res,2002,22:2413-2418. 被引量：1
8de Gramont A,Boni C,Navarro M,et al.Oxaliplatin/5-FU/LV in adjuvant colon cancer;Updated efficacy results of the MOSAIC trial,including survival,with amedian follow-up of six years.J Clin Oncol,2007,25:18S4007. 被引量：1
9Kuebler JP,Wieand HS,O Connell MJ,et al.Oxaliplatin combined with weekly bolus fluorouracil and leucovorin as surgical adjuvant chemotherapy for stage Ⅱ and Ⅲ colon cancer;results from NSABP C-07.J Clin Onclo,2007,25:2198-2204. 被引量：1
4Sawada N, Ishikawa T, Sekiguchi F, et al. X-ray irradiation induces thymidine phosphorylase and enhances the efficacy of capecitabine (Xeloda) in human cancer xenografts. Clin Cancer Res, 1999, 5: 2948-2953. 被引量：1
5The evaluation of low dose preoperative X-ray therapy in the management of operable rectal cancer; results of randomly controlled trial. Br J Surg, 1984, 71: 21-25. 被引量：1
6Di Betta E, D'Hoore A, Filez L, et al. Sphincter saving rectum resection is the standard procedure for low rectal cancer, Int J Colorectal Dis, 2003, 18: 463-469. 被引量：1
7Kapiteijn E, Marijnen CA, Nagtegaal ID, et al. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med, 2001,345 : 638-646. 被引量：1
8Marr R, Birbeck K, Garvican J, et al. The modern abdominoperineal excision : the next challenge after total mesorectal excision. Ann Surg, 2005, 242:74-82. 被引量：1
9Birbeck KF, Macklin CP, Tiffin N J, et al. Bates of circumferential resection margin involvement vary between surgeons and predict outcomes in rectal cancer surgery. Ann Surg,2002, 235:449-457. 被引量：1
10Nagtegaal ID, Marijnen CA, Kranenbarg EK, et al.Circumferential margin involvement is still an important predictor of local recurrence in rectal carcinoma: not one millimeter but two millimetera is the limit. Am J Surg Pathol, 2002, 26:350-357. 被引量：1
3Lee JJ, Kim TM, Yu SJ. Single-agent capecitabine in patients with metastatic colorectal cancerrefractory to 5-fluorouracil/leuco- vorin chemotherapy. Jpn Clin Oncol,2009,29(12) :1167-1169. 被引量：1
4Suenaga M, Nishina T, Hyodo I, et al. A feasibility study of ox- aliplatin (L-OHP) in combination with infusionalS-FU/1-LV ( FOLFOX4 regimen) for advanced colorectal cancer. Gan To Ka- gaku Ryoho, 2008,35 ( 2 ) : 2552 -2560. 被引量：1
5Fakih MG, Groman A, McMahon J, et al. A randomized phase II study of two doses of vorinostat in combination withS-FU/LV in patients with refractory colorectal cancer. Cancer Chemother Pharmacol, 2012,69 ( 3 ) : 743 -751. 被引量：1
6Duffaud F, Therasse P. New guidelines to evaluate the re- sponse to treatment in solid tumors [ J ]. Bull Cancer,2000, 87 (12) :881 - 886. 被引量：1
